Strategy of treatment for hepatocellular carcinomas with vascular infiltration in patients undergoing hepatectomy

J Surg Oncol. 2010 Jun 1;101(7):557-63. doi: 10.1002/jso.21534.

Abstract

Background and objectives: Vascular infiltration (VI) is an important prognostic factor for hepatocellular carcinoma (HCC) and predictive parameters are necessary to preoperatively decide treatment strategies in patients with HCC.

Methods: Relationships between presence and degree of VI in the portal and hepatic veins and bile duct, and post-hepatectomy survival were examined in 271 HCC patients who underwent hepatectomy.

Results: VI was observed in 81 patients (30%). Disease-free and overall survival rates was significantly lower in patients with VI than in patients without VI, and became poorer according to the degree of infiltration (P < 0.01). Multiple, increased size, non-meeting of Milan criteria, irregular macroscopic findings and increased PIVKA-II levels were associated with degree of VI in portal vein (P < 0.01). Increased size and increased PIVKA-II level were associated with degree of VI in hepatic vein (P < 0.05). Non-meeting of Milan criteria was associated with degree of infiltration in bile duct (P = 0.034). Survival was significantly better following anatomical resection than with non-anatomical resection and, furthermore, survival was better with surgical margins >5 mm than with shorter margins in patients who underwent non-anatomical resection.

Conclusion: Adequate extent of operative procedures, but not limited resection with short margins, is useful when predictive parameters associated with VI are observed.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Bile Ducts / metabolism
  • Biomarkers / blood
  • Carcinoma, Hepatocellular / pathology
  • Carcinoma, Hepatocellular / surgery*
  • Female
  • Hepatectomy / methods*
  • Hepatic Veins / metabolism
  • Humans
  • Japan
  • Liver Neoplasms / pathology
  • Liver Neoplasms / surgery*
  • Male
  • Middle Aged
  • Neoplastic Cells, Circulating*
  • Patient Selection
  • Portal Vein / metabolism
  • Prognosis
  • Protein Precursors / blood
  • Prothrombin
  • Survival Analysis

Substances

  • Biomarkers
  • Protein Precursors
  • acarboxyprothrombin
  • Prothrombin